Immunohistochemical detection of hepatitis C virus (genotype 4) in B-cell NHL in an Egyptian population: Correlation with serum HCV-RNA

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 1, 2010, Pages 29-34

  Gouda, Iman ^a   Nada, Ola ^b   Ezzat, Sameera ^c   Eldaly, Mai ^c   Loffredo, Christopher ^d   Taylor, Clive ^e   Abdel Hamid, Mohamed ^f  

^a NATIONAL CANCER INSTITUTE   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

^d Minia University ^*  (Egypt)

^e GEORGETOWN UNIVERSITY   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Hepatitis C virus; Immunohistochemistry; Non Hodgkin lymphoma

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD SAMPLING; CANCER TISSUE; CLINICAL ARTICLE; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL; MALE; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIRUS DETECTION; VIRUS LOAD; VIRUS STRAIN;

ADULT; AGE FACTORS; CYTOPLASM; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RNA, VIRAL; SEX FACTORS;

EID: 76149098822     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181ae9e82     Document Type: Article

References (37)

1. Hausen HZ, Schulte-Holthausen H, Klein G, et al. EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature. 1970;228:1056-1058.
2. Brousset P, Knecht H, Rubin B, et al. Demonstration of Epstein- Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood. 1993;82:872-876.
3. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982;79: 2031-2035.
4. Morris JDH, Eddleson ALWF, Crook T. Viral infection and cancer. Lancet. 1995;346:54-58.
5. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996;88:645-656.
6. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcomaassociated herpesvirus-like DNA sequences in AIDS-related bodycavity- based lymphomas. N Eng J Med. 1995;332:1186-1191.
7. Zignego AL, Giannini C, Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol. 2007;13:2467-2478.
8. Cowgill K, Loffredo C, Eissa SA, et al. Case-control study of non- Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol. 2004;33:1034-1039.
9. Lavanchy D, McMahon B. Worldwide prevalence and prevention of hepatitis C. In: Liang TJ, Hoofnagle JH. Hepatitis C. San Diego, CA: Academic Press; 2000.
10. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355:887-891.
11. Houghton M, Weiner A, Kuo G, et al. Molecular biology of hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991;14:381-388.
12. Duberg AS, Nordstrom M, Torner A, et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology. 2005;41:652-659.
13. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15:2078-2085.
14. Nieters A, Kallinowski B, Brennan P, et al. Hepatitis C and risk of lymphoma: results of the European Multicenter Case-Control Study EPILYMPH. Gastroenterology. 2006;131:1879-1886. (Pubitemid 44958516)
15. Spinelli JJ, Lai AS, Krajden M, et al. Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada. Int J Cancer. 2008;122:630-633.
16. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89-94. (Pubitemid 34753478)
17. Gisbert JP, Garcia-Buey L, Pajares JM, et al. Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther. 2005;21:653-662.
18. Svoboda J, Andreadis C, Downs LH, et al. Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection. Leuk Lymphoma. 2005;46:1365-1368.
19. Ramos-Casals M, Trejo O, Garcia-Carrasco M, et al. Mixed cryoglobulinemia: new concepts. Lupus. 2000;9:83-91.
20. Sansonno D, De Vita S, Carnacchiulo V, et al. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or nonneoplastic lymphoproliferation. Blood. 1996;88:4638-4645.
21. Zignego AL, Ferri C, Innocenti F, et al. Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection. Blood. 1997;89: 3066-3068.
22. Tursi A, Brandimanta G, Chiarelli F, et al. Detection of HCV RNA in gastric mucosa associated lymphoid tissue by in situ hybridization: evidence of a new extrahepatic localization of HCV with increased risk of gastric malt lymphoma. Am J Gastroenterol. 2002; 97:1802-1806.
23. De Vita S, Dammacco F, Gloghini A, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood. 1995;86:1887-1892.
24. Paydas S, Ergin M, Tanriverdi K, et al. Detection of Hepatitis C virus RNA in paraffin-embedded tissues from patients with non- Hodgkin lymphoma. Am J Hematol. 2004;76:252-257.
25. Karavatthayyil SJ, Kalkeri G, Liu HJ, et al. Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin's lymphoma. Am J Clin Pathol. 2000;113:391-396.
26. Jaffee ES, Harris NL, Stein H, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001:10-11.
27. Abdel-Hamid M, Edelman DC, Highsmith WE, et al. Optimization, assessment, and proposed use of a direct nested reverse transcriptionpolymerase chain reaction protocol for the detection of hepatitis C virus. J Hum Virol. 1997;1:58-65.
28. Okamoto S, Okada S, Sugiyama J, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 58-noncoding region. Jpn J Exp Med. 1990;60:215-222.
29. Habib M, Mohamed MK, Abdel-Aziz F, et al. Hepatitis C virus infection in a community in the Nile delta: risk factors for seropositivity. Hepatology. 2001;33:248-253.
30. El-Sayed GM, Mohamed WS, Nouh MA, et al. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients. Egypt J Immunol. 2006;13:105-114.
31. De Sanjose A, Benavente Y, Vajdic CM, et al. Hepatitis C and non- Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008;6:451-458.
32. Anderson L, Engels EA. Hepatitis C virus infection and non- Hodgkin lymphoma: interesting association or causal relationship? Int J Cancer. 2008;122:x-xii.
33. Gowans EJ. Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis. 2000;20:85-102.
34. Hamoud M, Villegas P, Williams S. Detection of infectious bursal disease virus from formalin-fixed paraffin-embedded tissue by immunohistochemistry and real-time reverse transcription polymerase chain reaction. J Vet Diagn Invest. 2007;19:35-42.
35. Yan FM, Chen AS, Hao F, et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.World J Gastroenterol. 2000;6:805.
36. De Vita S, De Re V, Sansonno D, et al. Lack of HCV infection in malignant cells refutes the hypothesis of a direct transforming action of the virus in the pathogenesis of HCV-associated B-cell NHLs. Tumori. 2002;88:400-406.
37. Machida K, Cheng KT, Sung VM, et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA. 2004;101:4262-4267.